HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Fuss Selected Research

Radiotherapy

3/2018Analysis of Magnetic Resonance Image Signal Fluctuations Acquired During MR-Guided Radiotherapy.
1/2018Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
1/2015The impact of anatomic tumor location on inter-fraction tumor motion during lung stereotactic body radiation therapy (SBRT).
1/2014Volumetric-modulated arc radiotherapy for pancreatic malignancies: dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
5/2013Dosimetric comparison of patient setup strategies in stereotactic body radiation therapy for lung cancer.
1/2013Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal-structure dose-volume metrics.
10/2010Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET).
8/2009Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results.
7/2009Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study.
4/2009Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Fuss Research Topics

Disease

12Neoplasms (Cancer)
03/2018 - 02/2004
3Cognitive Dysfunction
10/2009 - 05/2007
3Carcinoma (Carcinomatosis)
10/2006 - 01/2003
2Glioblastoma (Glioblastoma Multiforme)
03/2018 - 07/2007
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2004
2AIDS-Related Complex (ARC)
01/2014 - 07/2009
2Prostatic Neoplasms (Prostate Cancer)
09/2013 - 12/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2007 - 11/2005
1Fibrosis (Cirrhosis)
01/2018
1Lung Neoplasms (Lung Cancer)
05/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013
1Adenocarcinoma
08/2009
1Brain Neoplasms (Brain Tumor)
06/2007
1Meningioma (Meningiomas)
11/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2002
1Neoplasm Metastasis (Metastasis)
05/2002
1Acoustic Neuroma (Acoustic Neurinoma)
01/2002

Drug/Important Bio-Agent (IBA)

1hydroxide ionIBA
03/2018
1BilirubinIBA
01/2018
1AlbuminsIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
10/2010
1Prostate-Specific Antigen (Semenogelase)IBA
07/2004

Therapy/Procedure

19Radiotherapy
03/2018 - 11/2003
8Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2014 - 01/2002
3Cranial Irradiation
10/2009 - 05/2002
2Therapeutics
03/2018 - 10/2010
2Conformal Radiotherapy
01/2014 - 07/2009
2Drug Therapy (Chemotherapy)
10/2010 - 05/2002
1Combined Modality Therapy
11/2005
1Image-Guided Radiotherapy
11/2004
1Patient Positioning
07/2004
1Chemoradiotherapy
01/2003